The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

The FDA has approved Journavx, a new non-opioid painkiller by Vertex Pharmaceuticals. It offers post-surgical pain relief without addiction risks but is less effective than opioids. With a high cost ...

The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The drug is called Journavx and doctors believe it has no potential for addiction and dependence.

In today’s time of endless scrolling and spending a lot of time on the internet, experts say technology addiction—just like other dependencies—is a real thing. While it may not be recognised as a ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and Drug ...

A doctor with NYU says this new pill is not addictive. A mother who lost her son from opioid addiction hopes for the best but wants to see if this new pill will truly be a safe alternative.

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...